Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
arrive, Bahrain, Biden, biomarker, Biopharma, bridging, Britain, built, burden, Bylvay, California, CCPA, Colorado, commensurate, Congressional, constant, constitutionality, copy, cybersecurity, CymaBay, departure, disciplinary, dismissed, distributor, downturn, dramatic, Eastern, easy, ECG, EMEA, enjoined, environmental, executory, floor, GCC, Gen, Genpharm, great, hand, HBV, HDV, hematology, hepatic, IBR, ID, implicit, inadvertently, intensified, inventory, Ireland, Italy, Jadeite, Kuwait, la, labor, levied, LIVMARLI, Marley, Medison, medium, MHRA, misleading, obsolete, occupancy, offender, older, Oman, Omicron, OPDP, paradigm, Portugal, preapproval, pregnancy, prompt, PTE, Qatar, rapid, rebate, recurring, redemption, refrain, regular, remote, remotely, renal, reside, resignation, Resiliency, Roadmap, Russia, Sanayi, seasoned, Seladelpar, session, Spain, Street, sublease, subleased, sublicensee, subtype, Swixx, tariff, Ticaret, UAE, Ukraine, unopened, upheld, vaccination, ve, Virginia, virtually, weaker, Western, withdrew, withstand
Removed:
abnormal, absolute, Africa, alanine, Allergan, ALT, aminotransferase, Amitiza, analyzed, Ardelyx, AST, audience, Australia, banking, basal, Bausch, Belgium, belong, bisacodyl, BLA, bleeding, bloating, blockage, bone, breast, Bristol, calcium, Canada, capsule, cardiovascular, carpal, cell, Cephulac, chloride, chosen, Citrucel, Colace, Colestyr, confirmation, consecutive, consistently, Constella, correlate, correlated, corroborative, cyclase, Czech, developmental, diagnostic, discontinuation, discontinued, diverticulum, docusate, Ducolax, enema, escalating, evacuation, exacerbate, exacerbation, Exlax, experiencing, fatty, feedback, fiber, FiberCon, Fleet, formed, Foundation, fulfill, gallbladder, glaucoma, glycol, guanylate, guide, hard, Hungary, husk, hydroxide, hypertension, hysterectomy, identification, influenced, innovative, internally, Ironwood, irritable, lactulose, laxative, linaclotide, lip, lipid, lubiprostone, lumpy, Magnesia, magnesium, manual, medically, Metamucil, methylcellulose, Milk, MiraLax, moderate, Motegrity, motility, Mylan, nausea, nonalcoholic, obstruction, OCA, occasional, occurring, onset, originally, OTC, outpouring, outset, pain, passing, path, plc, plecanatide, Poland, polycarbophil, polyethylene, powered, precisely, predefined, prucalopride, psyllium, Questran, randomization, rarely, ratio, rebound, receptor, rectal, region, releasing, replicate, Republic, Resolor, rest, Roger, Rome, SAE, safely, saline, score, screening, sensation, separation, Shire, shoulder, Slovakia, sorbitol, South, spinout, sprinkled, Squibb, stable, sterling, straight, straining, suppository, tablet, Takeda, tenapanor, transient, Trulance, tumor, tunnel, unproven, usage, uterine, utility, Vermont, water, worsening, York
Filing tables
Filing exhibits
Related press release
Associated ALBO transcripts
ALBO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
1. | Registration Statements (Form S-3 Nos. 333-238063, 333-241680 and 333-253506) of Albireo Pharma, Inc., and |
2. | Registration Statements (Form S-8 Nos. 333-144407, 333-168903, 333-180409, 333-215264, 333-222131, 333-226718, 333-228280, 333-233111, and 333-2535000) pertaining to equity incentive plans of Albireo Pharma, Inc; |
of our report dated March 1, 2022, with respect to the consolidated financial statements of Albireo Pharma, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2021.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 1, 2022